MYOD1 and melanoma: Additionally, the lack of MyoD1 and S100 expression eliminates the possibility of rhabdomyosarcoma (Lak et al. 2021) and melanoma (Neubert et al. 2018), respectively, as these markers are known to be sensitive to those conditions.